Owing to its central role in DNA synthesis, human thymidylate synthase (hTS) is a well-established target for chemotherapeutic agents, such as fluoropyrimidines. The use of hTS inhibitors in cancer therapy is limited by their toxicity and the development of cellular drug resistance. Here, with the aim of shedding light on the structural role of the A-helix in fluoropyrimidine resistance, we have created a fluoropyrimidine-resistant mutant by making a single point mutation, Glu30Trp. We postulated that residue 30, which is located in the A-helix, close to but outside the enzyme active site, could have a long-range effect on inhibitor binding. The mutant shows 100 times lower specific activity with respect to the wild-type hTS and is resistant to the classical inhibitor, FdUMP, as shown by a 6-fold higher inhibition constant. Circular dichroism experiments show that the mutant is folded. The results of molecular modeling and simulation suggest that the Glu30Trp mutation gives rise to resistance by altering the hydrogen-bond network between residue 30 and the active site.
Introduction
Human thymidylate synthase (hTS) (EC 2.1.1.45) catalyzes the reaction in which dUMP (2 0 -deoxyuridine-5 0 -monophosphate) is methylated by 5, 6, 7, 8, to form dTMP (2 0 -deoxythymidine-5 0 -monophosphate) and the reduced cofactor 7,8-dihydrofolate (DHF). This reaction is the only de novo source of dTMP in human cells and, for this reason, hTS is essential for DNA biosynthesis (Carreras and Santi, 1995; Schiffer et al., 1995; Finer-Moore et al., 2003) . Inactivation of this enzyme results in thymineless cell death. The central role of hTS makes it an attractive target for chemotherapeutic agents. Indeed, fluoropyrimidines and folate-like drugs, which are used in the treatment of colorectal, ovarian and breast cancer (Heidelberger et al., 1957; Danenberg, 1977; Jackman and Calvert, 1995; Touroutoglou and Pazdur, 1996; Sergeeva et al., 2003) , inhibit thymidylate synthase.
One of the mechanisms by which fluoropyrimidine-resistance in humans develops is the mutation of hTS (Banerjee et al., 1999) . We will refer to such hTS mutants that have reduced affinity for the drug as fluoropyrimidine-resistant mutants of hTS. Several fluoropyrimidine-resistant mutants of hTS are known and it has been found that these mutations occur throughout the entire protein sequence, not only near the active site (Landis and Loeb, 1998; Tong et al., 1998b; Landis et al., 1999 Landis et al., , 2001 Kawate et al., 2002; Forsthoefel et al., 2004) . The first and only natural mutant that was identified to be resistant to fluoropyrimidines, such as 5-fluoro-2 0 -deoxyuridine-5 0 -monophosphate (FdUMP), has a Tyr33His substitution (Berger et al., 1988; Barbour et al., 1990; Reilly et al., 1997) . Residue 33 is located in the second shell of amino acid residues surrounding the active site ( Fig. 1) , near the N-terminus on the a-helix formed by residues 29-44 (helix A). This helix resides on the protein surface and its specific role is unknown. Other mutations at residue 33 showed a diversity of effects on enzyme activity, ranging from no effect to removal of activity, suggesting that the A-helix is an important structural element for the integrity of the binding site (Reilly et al., 1997) .
Since the Tyr33His mutation and other mutations occurring along the hTS sequence can confer drug resistance, it is possible that, in addition to their local effect, the mutations also have a long-range structural effect on ligand binding. This proposal is supported by crystallographic studies of thymidylate synthase which have established that the large conformational changes occurring upon binding the substrate and the cofactor involve the whole protein structure . However, there is no clear explanation available at the molecular level for the observed decrease in FdUMP affinity of these mutants.
We speculated that another mutation in the A-helix region could modify the enzyme activity by long-range interference with the active site and result in resistance. We chose Glu30 because it is directed toward the enzyme core. It forms a hydrogen bond network with Thr-75 and Thr-76 (Sotelo-Mundo et al., 1999) . Since it is located at the beginning of the A-helix and not in the middle, even a dramatic conformational change at the mutation site would not be expected to cause a complete disruption of the A-helix or to strongly perturb the whole enzyme tertiary structure. On the other hand, to induce significant local modifications and disrupt the residue's hydrogen bonds, we decided to mutate Glu30 to a bulky, neutral residue, Trp. The crystal structure of the WT protein shows that the Trp side chain could be accommodated at residue 30 with some local structural rearrangement (see Supplementary material, section C, available at PEDS online). A similar mutation of Tyr33 to Trp resulted in a decrease of, but not absence of, enzyme activity (Reilly et al., 1997) . Our purpose was to establish whether the selected residue (30) can be exploited to affect enzyme activity and inhibitor binding, thus giving detailed information, not only on this residue but also on the structural role of the A-helix.
Here, we have characterized the interaction of the wildtype (WT) and mutant hTS proteins with FdUMP by kinetic analysis. In addition, isothermal titration calorimetry (ITC) experiments were performed to study the interaction of hTS with FdUMP and characterize the thermodynamic constants of the enzyme -inhibitor complex without the folate cofactor and thereby provide a key model to interpret the kinetics of the mutated enzyme. Circular dichroism (CD) analysis was applied to study the effect of the mutation on the folding and secondary structure of the protein. Molecular modeling and simulation studies were performed to aid the interpretation of the structural and dynamic effects of the mutation. The naturally occurring Tyr33His mutant was included in the modeling studies for reference. The results of the present work help to provide a mechanistic understanding of the effect of A-helix mutation on FdUMP affinity and the structural basis of FdUMP resistance.
Materials and methods

Cell lines and materials
FdUMP, sodium dodecyl sulfate (SDS) and ethylenediaminetetraacetic acid (EDTA) were purchased from Sigma. All reagents used for the enzyme purification, enzyme kinetics and ITC experiments were of the highest purity available. The hTS WT plasmid and strain were supplied by Dr D.V. Santi (University of California, San Francisco, CA, USA; present address: Kosan, San Francisco, CA, USA) and Dr G.F. Maley (New York State Department of Health, New York).
The plasmid pET17-xb containing the WT hTS cDNA gene was cloned under control of the b-gal promoter. The plasmid vector also contained the T7 promoter, the gene for ampicillin resistance for clonal selection and the Ori sequence for replication in Escherichia coli. The plasmid was isolated from E.coli BL21 strain DE3pLysS using the Maxiprep Kit (Qiagen). The plasmid DNA concentration was determined by UV absorbance at 260 nm and, to verify the purification of the hTS plasmid, the Maxiprep product was digested using HindIII and NdeI.
Mutagenesis
The single point mutation was made with a Quick Change Site-Directed Mutagenesis Kit (Stratagene) that utilizes PfuUltra w high-fidelity DNA polymerase for primer extension (see Supplementary material, section A, available at PEDS online).
Sequencing
The plasmid obtained with Miniprep from XL1-Blue cells was sequenced using the BigDye Terminator 1.1 Cycle Sequencing (Applied Biosystem), based on a chain termination method. The reaction mixture contained 1 mg of plasmid, 50 ng of primer and 8 ml of Terminator Ready Reaction Mix. The reaction was conducted in a Primus Thermal Cycler (MWG-Biotech), and the product was purified and analyzed using a 3100 Genetic Analyzer (Applied Biosystem).
Wild-type and mutant purification hTS purification was carried out following Maley's protocol with small modifications (Pedersen-Lane et al., 1997) (see Supplementary material, section A, available at PEDS online).
Mass spectrometry
After a new separation in SDS -PAGE, the hTS mutant was digested with trypsin and then analyzed by mass spectrometry. Mass spectra were recorded by using the Spectrometer Q-Tof Global Ultima (Micromass) equipped with an electrospray ionization source and connected with nano-HPLC. The spectra were analyzed by using the Mass Lynx and the free Mascot software (www.matrixscience. com). Peptides containing the mutation were observed.
Kinetic analysis
hTS activity was determined spectrophotometrically by monitoring the increase in absorbance at 340 nm during the oxidation reaction of mTHF to DHF. The reaction mixture contained 50 mM of TES buffer (TES, N-[tris(hydroxymethyl)methyl]-2-aminoethanesulphonic acid 100 mM, MgCl 2 50 mM, formalin 13 mM, EDTA 2 mM, b-mercaptoethanol 150 mM, pH 7.4), the enzyme at 0.9 mM concentration, 120 mM of mTHF and water to 800 ml. The reaction was initiated when dUMP (120 mM) was added to the reaction mixture. The Michaelis -Menten constant (K M ) was determined for mTHF and dUMP. The concentration ranges for the K M measurements were 10 -300 mM for mTHF and 3 -100 mM for dUMP. The values for k cat were also determined. K i values for FdUMP were obtained by steady-state kinetic analysis at varying inhibitor concentration (0.05 -5 mM). The inhibition mixture contained 50 mM of TES buffer, 1 mM enzyme, 15 mM of dUMP and water to 800 ml. The reaction was started when mTHF was added at 120 mM. K i values were obtained from the linear least-squares fit of the residual activity as a function of inhibitor concentration, using suitable equations for classical and tight binding competitive inhibition (Williams and Morrison, 1979; Kuzmic et al., 2000) .
Isothermal titration calorimetry
Calorimetric experiments were performed using a MicroCal w VP-ITC MicroCalorimeter. Prior to ITC experiments, both enzyme and buffer solutions were filtered (0.45 mM filter) and thoroughly degassed. The reference cell was filled with 1.5 ml of Milli-Q water. A 0.025 mM hTS KPi buffer solution (20 mM, pH 7.5) containing 0.1 mM EDTA was placed in the calorimeter cell and FdUMP (0.25 mM) was added to the cell via the rotating stirrer-syringe. The injection volume was 10 ml and an equilibration time of 4 min was allowed between each injection. The total number of injections was 28. Blank titrations were performed by injecting the ligand into the buffer devoid of protein to correct for the heat of mixing and ligand dilution. These contributions to the observed heats of reaction were then subtracted from the corresponding total heats. The heat effect of the enzyme dilution due to titrant injection was negligible in all cases. Values of the association constant, enthalpy and entropy were obtained by fitting the integrated heats of association to a two sequential binding sites model, using the software supplied with the instrument.
Circular dichroism
CD spectra of the WT and E30W mutant hTS proteins were measured on a Jasco J-810 spectropolarimeter. Samples were prepared in KPi buffer solution (10 mM, pH 7.5) containing 1 mM EDTA and measurements were performed at room temperature (ca. 258C) in cuvettes with various path lengths: 0.1 cm for the peptide absorption region (180 -240 nm) and either 0.4 or 1 cm for the aromatic residue absorption region (250-320 nm). Maximum absorbances were between 0.5 and 1. Buffer signals were subtracted, but no other correction was introduced. Protein concentrations were determined spectrophotometrically at the lowest-energy tyrosine/ , mol ¼ moles of residues) using the known number of residues per dimer of the WT hTS (650) and E30W mutated hTS (626). Spectra in the peptide absorption region were quantitatively analyzed using the programs available at the Dichroweb site (http ://dichroweb.cryst.bbk.ac.uk) (Lobley and Wallace, 2001; Lobley et al., 2002; Wallace, 2004, 2008) (Supplementary material, section B, available at PEDS online).
Computational methods
Protein structure preparation The crystal structure (Phan et al., 2001) of the hTS ternary complex [PDB (http://www. pdb.org/) code 1HVY, chains A and B] provided a template for the WT and mutant hTS models. The SYBYL modeling package (SYBYL v. 7.2 and 7.3, Tripos Associates, Inc., St Louis, MO, USA, http://www.tripos.com) was used for model building and structural modification of the template (Supplementary material, section C, available at PEDS online).
Ligand structure preparation Two models were constructed for each of the proteins: one with the substrate dUMP and cofactor mTHF and the other with the inhibitor FdUMP and mTHF in the active site. The structure of the co-crystallized dUMP from the template (1HVY) was kept as was. The atom types were corrected and hydrogens were added in the context of the protein with the SYBYL Biopolymer module. To model FdUMP, a fluorine atom was added on the C5 atom of dUMP. The coordinates of THF were taken from the crystal structure 1KZI (Fritz et al., 2002) and merged with our hTS models. Then the mTHF imidazoline ring was closed, such that the cofactor adopted a highly bent conformation. Ligand parameters for the molecular dynamics (MD) simulations with the AMBER 8 simulation package (Case et al., 2005) were defined by combining data from the AMBER 8 nucleic acid parameter library (nucleic02.lib) and from Dr A. Jarmula (Jarmula et al., 2003 (Jarmula et al., , 2005 (Jarmula et al., , 2007 ) (see Supplementary material, section D, available at PEDS online).
Normal mode analysis A normal mode analysis using the elastic network model was performed on the modeled structures. The web server NOMAD-Ref (Lindahl et al., 2006) (http://lorentz.immstr.pasteur.fr/nomad-ref.php), which takes all non-hydrogen protein atoms into account in the calculations, was used so that the possible effect of the mutated side chain could be detected. The 14 lowest-frequency modes (apart from the six rigid body translation and rotation modes) were calculated using the full matrix solver method, setting the following parameters: 5.0 Å average RMSD in output trajectories, a cut-off for model calculation of 10 Å and a distance weight parameter of 5.0 Å . Ligands, hydrogen atoms and water molecules were omitted from the calculations.
MD simulations MD simulations of the WT and Glu30Trp and Tyr33His mutants, with either dUMP or FdUMP and mTHF, were performed with the AMBER 8 MD simulation package using the AMBER ff03 forcefield (Duan et al., 2003) for the proteins and the AMBER general atom forcefield (GAFF) for the ligands. After minimization and equilibration (see Supplementary material, section E, available at PEDS online), a production run of 4 ns was performed. The final frame structures from the MD simulations were energy minimized (same procedure as before MD) and used for the normal mode analysis. H-bond occupancies in the protein structures during the MD simulations were calculated with the CARNAL module of AMBER 7 (distance between nonhydrogen atoms 3.5 Å , angle 608).
FIRST/FRODA analysis FIRST v. 5.2 (Floppy Inclusions and Rigid Substructure Topography) Thorpe, 1995, 1998; Jacobs et al., 2001; Thorpe et al., 2001 ) and its module FRODA (Framework Rigidity Optimized Dynamics Algorithm) (Wells et al., 2005) were used to analyze the structural rigidity and flexibility of the protein structures and to explore the conformational space available to their flexible regions. Subsequently, Interactive Essential Dynamics (IED v. 2.02) (Amadei et al., 1993; Mongan, 2004 ) was applied to examine whether the essential movements of the mutants differed from those of the WT enzyme (Supplementary material, sections I, J and M, available at PEDS online).
Results
Protein preparation and kinetic characterization
The Glu30Trp hTS mutation was successfully made and protein purification was performed following the same protocol as for the WT hTS.
The interaction of hTS and FdUMP has been well characterized previously (Reyes and Heidelberger, 1965; Danenberg and Lockshin, 1981; Santi et al., 1987; Reilly et al., 1995) . FdUMP was found to be a tight binding inhibitor that forms a stable ternary complex with hTS and mTHF, following an ordered binding in which the cofactor is added first. The thermodynamic parameters of the interaction, as determined by chemical quench (CQ) studies, showed a stoichiometry of 2 FdUMP: 1 hTS dimer with K d values of 64 nM for the first binding site and 47 mM for the second one (Reilly et al., 1995) . When FdUMP is added to the reaction mixture first and it is not incubated with folate, the K d decreases because a non-covalent binary complex is detected.
Here, the WT hTS and the Glu30Trp mutant were characterized and K M values for the substrate dUMP and the cofactor mTHF were measured, together with k cat (catalytic constant), specific activity and specificity (k cat /K M ). The enzyme activity was determined spectrophotometrically by steady-state kinetic analysis. The overall enzyme activity decreased upon mutation as indicated by the 12-fold reduction in k cat of Glu30Trp with respect to that of the WT enzyme (Table I ). The K M value for dUMP of the Glu30Trp mutant was not significantly different from that of the WT enzyme, suggesting that substitution of this residue does not alter the affinity of the enzyme for dUMP. k cat /K M dUMP, which represents the efficiency of the enzyme, reflected the k cat change and is eight times lower for the mutant than the WT enzyme. The K M of the mutant enzyme for mTHF was 35-fold higher than that of the WT. The decreased binding affinity of the cofactor suggests that the mutation caused a long range alteration of the folate binding site conformation, making this site less accessible. Accordingly, k cat /K M mTHF was decreased 457 times, indicating a lower turnover capacity of the enzyme in product delivery.
We characterized the interaction of the Glu30Trp mutant with FdUMP by measuring K i and K d parameters for formation of the binary complex. The K i of FdUMP for the mutant (1.10 mM) was $10 times higher than that for the WT (0.17 mM) (see Supplementary material, section A, Table S1 , available at PEDS online). The value of K i for WT is similar to that reported by Kawate et al. (2002) (K i ¼0.16 mM) but differs from that reported by Tong et al. (1998a) 
These results with rather high K i values show that a tight binding inhibition process does not occur when FdUMP and dUMP are combined in competitive concentrations and the cofactor mTHF is added to start the reaction. This order of addition of the reagents prevents the formation of the inhibitory ternary complex (hTS-FdUMP-mTHF) which occurs when mTHF and FdUMP are mixed prior to the addition of dUMP (Tong et al., 1998a; Kawate et al., 2002) . Instead, in our case, the measured K i values reflect the competition of FdUMP and dUMP in forming first a binary complex with the enzyme. With this kinetic model, we could compare these results directly with those from ITC experiments in which only the binary complex FdUMP-TS was examined.
Isothermal titration calorimetry of the FdUMP-hTS interaction
To support the concept that the measured K i values describe the formation of a binary complex, we determined the K d for formation of the FdUMP-hTS complex using ITC (Fig. 2 and Table II ). The results of the calorimetric titration experiment for the interaction between FdUMP and hTS optimally describe a two sequential binding sites model (Fig. 2) . The whole binding event is exothermic, and both enthalpic (DH) and entropic (DS) variations are favorable for each interaction site. The first molecule of FdUMP binds hTS with a $175-fold higher affinity than the second molecule of FdUMP, as indicated by the difference in binding affinity for sites 1 and 2. The enthalpic variation suggests a negative cooperativity between the two binding sites.
The difference of three orders of magnitude between the measured binding constants for sites 1 and 2 of hTS that we have observed is consistent with the previously reported values for the covalent ternary complex (hTS-FdUMPmTHF) determined by CQ analysis (K d of 6.4 Â 10 210 and 
Â 10
27 M, respectively, for sites 1 and 2) (Reilly et al., 1995) . The variation in the data collected by the two different studies can be explained by considering that the ITC experiments in this work were conducted in the absence of mTHF. This causes a decrease in the binding affinity of FdUMP to its interaction site. The mTHF acts as a conformational inducer that produces a better interaction site for FdUMP (Kawate et al., 2002) . In the presence of mTHF, a covalent ternary complex is formed, but this event cannot be measured by the ITC technique. It is important to observe that the measured K d for the formation of the binary complex is close to the observed K i in the kinetic experiments.
Comparing the K i and K d measured for the interaction of FdUMP and hTS in kinetic and ITC experiments, it is clear that the two constants are in the same range, 0.17 and 0.59 mM. This suggests that the observed equilibrium is the same. In particular, for the ITC analysis, the enzyme is titrated with FdUMP, while in kinetic experiments, FdUMP is added first to the enzyme and then mTHF is injected. The similarity of the two data sets supports the observation that the folate cofactor helps the FdUMP inhibitor to bind tighter to the enzyme and reinforces the binding of FdUMP itself for the formation of a very stable ternary complex.
Circular dichroism
CD experiments were performed on both WT and Glu30Trp hTS to analyze the folding and secondary structure content of the two proteins. The CD spectra (Fig. 3) show that both proteins exhibit marked secondary structure motifs. The different calculation programs and reference data sets used (see Materials and methods) provided rather similar results, but the best fitting procedure was a combination of the CDSSTR method (Sreerama and Woody, 2000) with the SP175 reference data set in the 190-240 nm range (Lees et al., 2006) . The reconstructed spectra are shown as circles in Fig. 3 . The results show that both proteins have strong a-helical character. The mutation results in an increase in the fraction of residues in regular helices (Supplementary material, section B, available at PEDS online). The aromatic region of the CD spectrum (inset in Fig. 3 ) is mostly due to tyrosine residues, with weak, positive 1 L a contributions from tryptophans between 290 and 300 nm and two poorly resolved phenylalanine bands between 255 and 270 nm. The main effect of the mutation is a change in sign in the 255-295 nm region, from negative for the WT (minimum at 278 nm) to positive (maximum at 276 nm) for the mutated protein. It is therefore apparent that the average environment of the aromatic residues, particularly of buried tyrosines which are expected to contribute most to the Cotton effect, is somewhat modified as a consequence of the E30W mutation. Overall, the data show that the Glu30Trp mutant is folded The uncertainties are standard errors from two independent experiments. with a somewhat more helical secondary structure than the WT protein.
Molecular modeling
Functional movements of the wild-type and the mutant hTS structures Analysis of the normal modes calculated for the initial model structures and the energy-minimized final structures obtained from the MD simulations of the WT and the Glu30Trp and Tyr33His mutants revealed subtle differences in the motion of the region encompassing the N-terminus, helix A, helix K and the C-terminus in the three proteins (see Supplementary material, section G, Fig. S2 , available at PEDS online). The deviation from the WT movements was a little greater in the Glu30Trp mutant than in the Tyr33His mutant.
Most of the protein modes affect the ligand binding site, especially the mTHF binding site (Supplementary material, section H, available at PEDS online). In addition to the flexible N-terminus and floppy interface loop (IL, residues 141-159), the small domain (SD, residues 99 -129), the dUMP binding loop (DL, residues 45 -55) and the C-terminus undergo significant variation. The interface b-sheet is mostly very rigid. For example, the two lowest frequency modes for the initial model structures show how these regions are involved in the open-closure motion of the active site (see Fig. 4 . and Supplementary material, section G, Tables S2  and S3 , available at PEDS online). The above observations on the opening/closing of the active site are consistent with the reported conformational dynamics of the thymidylate synthase reaction pathway . Interestingly, it has been shown that bacterial and eukaryotic TSs demonstrate different dynamics which affect opening and closing of the active site and may contribute to the species-specificity of some types of inhibitors (Ferrari et al., 2003) .
Further analysis with FIRST and FRODA corroborated the results from the normal mode calculations. The interface b-sheet and the core helix J were identified as rigid regions by FIRST (Supplementary material, section I, available at PEDS online). The same domains as in the normal mode analysis and the MD trajectories were seen to be most mobile in the trajectory generated by FRODA (Supplementary material, sections J -L, available at PEDS online).
Essential dynamics analysis (Amadei et al., 1993) of the FRODA conformational ensembles and the MD trajectories revealed differences in the WT versus Glu30Trp/Tyr33His mutant motions (Supplementary material, section M, available at PEDS online). The motion along the first two eigenvectors of the FRODA ensembles, representing ca. 50-60% of the total variance, shows a similar type of closure motion of the active site to that seen in the normal mode analysis. However, differences between the movements of the WT and the mutants are evident, especially in the degree of motion of the SD, C-terminus and the region below helix K, resulting in differences in the size of the binding site (see Supplementary material, section M, Table S9 , available at PEDS online). The effect of the mutations studied on the degree of active site opening-closure is not as great as the differences between the bacterial and eukaryotic TSs (Ferrari et al., 2003) . The movements of the Glu30Trp and Tyr33His mutants are more similar to each other than either of them is to the movement of the WT (Fig. 5 ).
H-bond network analysis The Glu30Trp mutation induces conformational changes in the protein because the Trp30 side chain cannot fit in the crystal structure without steric obstruction (Supplementary material, section C, available at PEDS online). These clashes result in perturbation of the interactions between helix A and its surroundings and, in particular, the following H-bonds: His28-Arg274, Glu30-Thr75, Glu30-Thr76, Tyr33-Met219 and Gln32-Arg64.
With respect to the Gln32-Arg64 H-bond, Arg64 is located on the b-strand extending from Gly54 to Leu67 at the dimer interface (Fig. 6B) . It also interacts with Asp247 'open' and (B) 'closed' forms of hTS represented by the extrema of the structures generated along normal mode 2. DL, dUMP binding loop; SD, small domain; C, C-terminus; IL, interface loop; AS, active site loop. This low-frequency mode shows how the SD and the IL move toward the active site as the AS bends slightly toward the interface as a hinge. Simultaneously, the C-terminus -helix Khelix A-DL region twists aside as if backing up from the active site using the b-sheet kink as a hinge. In the 'closed' conformation, the C-terminus and the DL are closer to the SD and each other than in the 'open' conformation. The immediate regions involved in the closure of the active site are shown in black. The first two residues in the floppy N-terminus were deleted for clarity.
and Phe59
0 . Phe59 0 , located in the other monomer, can form p -p stacking or van der Waals interactions with residues at the interface (Gln200, Tyr202, Gln211) and with Asp254 0 . Asp254 0 interacts with residues that form H-bonds with the dUMP phosphate group in the active site, such as Arg175, Lys47 0 , Ser57 0 , Arg215 0 , Ser216 0 , Gly217 0 and His256 0 . Therefore, a possible perturbation of substrate binding in the adjacent monomer could result from alteration of helix A.
Met219 forms an H-bond and other contacts with Tyr33 just along helix A from residue 30 (Fig. 6A) . Met219 is located at the base of the helix J and interacts with the nearby residues of the same helix (Gly217, Asp218, Gly220, Leu221, Gly222, Val223, Pro224) as well as with Leu252 and His256. Asp218 and His256 are involved in the binding of dUMP and thus, it is possible that a mutation at position 30 affects dUMP binding in the same monomer.
Finally, of particular interest are the interactions between helix A and residues Thr75, Thr76 and Arg274 residing in the region below the C-terminus (Fig. 7A -C) . Thr75 forms H-bonds with His304 and Arg274; Thr76 forms H-bonds with Gln268 and Arg271; Arg274 forms H-bonds with Thr75 and Asn302. These residues interact with the C-terminal portion that is involved in substrate and cofactor binding when ligands enter into the active site. A comparative analysis of the known thymidylate synthase sequences of pathogenic organisms shows that the residue at position 30 can be substituted by an aspartic acid or a methionine in sequences that begin with such a residue. Interestingly, in E.coli thymidylate synthase, there are interactions between the corresponding Met1 and Thr48/Thr49 residues similar to those in hTS between Glu30 and Thr75/Thr76. These interactions are essential for maintaining enzyme stability during the ligand binding process (Finer-Moore et al., 1993 Fauman et al., 1994; Carreras and Santi, 1995) . Thus, perturbation of the H-bond network in this region can cause conformational changes in the C-terminus which can affect the cofactor/substrate binding and/or their interactions.
The dynamics of the above-described H-bond network around the mutated residues and the ligand binding site were followed in detail during the MD simulations (Figs 5 and 7 and Supplementary material, section N, available at PEDS online). This analysis permitted us to conclude that the H-bond network that affects the conformation of the C-terminus and the mTHF binding site is perturbed more by the mutations than is the H-bond network affecting the dUMP/FdUMP binding site. This evaluation is consistent with the experimental results and the effect is more pronounced for the Glu30Trp mutant than for the Tyr33His mutant. Specifically, examination of the occupancies of the His28-Arg274, Glu/Trp30-Thr75, Glu/Trp30-Thr76, Tyr/ His33-Met219 and Gln32-Arg64 H-bonds showed that the first three H-bonds are perturbed in the Glu30Trp mutant. These H-bonds can affect the conformation of the C-terminus via the H-bond network they are part of. The latter two H-bonds, associated with the (F)dUMP binding site, are not perturbed as much with respect to the WT enzyme. Arg64, for example, is located in the rigid b-sheet region and thus, does not move much.
Discussion
In this study, we investigated the effect that a mutation at position 30 in helix A of hTS has on the resistance of the enzyme to FdUMP. A new mutant of hTS, Glu30Trp, was designed, made and characterized by kinetic analysis, ITC, CD and molecular modeling. The mutant shows resistance, being six times less sensitive to FdUMP than the WT hTS. However, it also shows reduced activity compared with the WT, with a 35 times greater K M mTHF value and a 12 times smaller k cat value. The drop in k cat is similar to that measured previously for the clinically isolated Tyr33His mutant whose k cat value was reported to be eight times lower than for the WT (Barbour et al., 1990) . However, the K M values for dUMP and mTHF of the Tyr33His mutant were not significantly different from WT (Barbour et al., 1990) . Furthermore, the K d for the Glu30Trp mutant was six times higher than for the native enzyme, whereas for the Tyr33His mutant, it was only three times higher than that of the WT. Concomitant with these differences in the kinetic constants of the two mutants, the Glu30Trp mutation was found to have a stronger perturbative effect on the protein than the Tyr33His mutant.
CD studies performed on WT and mutated proteins show that both proteins are folded and show a more ordered secondary structure in the E30W mutant. The molecular modeling studies suggest that the mutation at position 30 in helix A perturbs the hydrogen-bond network and that this has a long-range effect on the ligand binding site. Specifically, the interaction network affecting the conformation of the C-terminus and thus, the cofactor binding site is more perturbed by mutation than the network affecting the (F)dUMP binding site either at the other monomer via residues that are located at the rigid dimer interface or within the same monomer via residues in a fairly rigid region between helix J and the middle b-strand (residues 207 -218) and at the second interface b-strand (residues 244 -258).
In summary, our study suggested that the introduction of Glu30Trp mutation on the A-helix alters the hydrogenbonding network of the protein thus affecting both folate cofactor and FdUMP binding. Comparison between the Glu30Trp and Try33His mutants shows that the Glu30Trp hTS mutant has a similar effect on k cat and a greater effect on cofactor binding affinity than the clinically detected Tyr33His mutant. These observations are consistent with the greater perturbation of the structure and dynamics of the protein by the Glu30Trp mutation than the Tyr33His mutation in the modeling and simulation studies. Finally, this study provides insights into the functional role of helix A and how the mutations can have a long-range effect, perturbing the dynamics and hydrogen-bonding networks of hTS, to modulate cofactor binding and catalysis and therefore affect inhibitor sensitivity. This is, to our knowledge, the first time that a mechanistic interpretation has been obtained to explain FdUMP resistance due to an A-helix mutation in hTS, and this suggests that the A-helix is involved in allosteric control of the active site conformation.
